乳腺癌淋巴结管理影像学进展
本文综述乳腺癌淋巴结转移的影像学评估进展,强调新辅助全身治疗(NST)背景下影像及影像引导淋巴结介入在分期、疗效监测及手术决策中的作用。文章讨论淋巴结转移的影像特征、影像引导操作技术,并比较各影像检查的优缺点及活检不可用时的应用策略。
要点
- NST后手术可降级,影像成为淋巴结评估主要手段
- 影像可评估所有区域淋巴结站,包括手术不常涉及部位
- 影像区分局限与广泛淋巴结受累,帮助决定初始治疗方式
核心结论
- 乳腺癌治疗多学科化及NST应用增加,使影像和影像引导淋巴结介入成为淋巴结评估的主要手段。
关键影像表现/征象
- 文章讨论淋巴结转移的影像特征,但摘要未给出具体征象描述。
临床应用与阅片要点
- 阅片时应评估所有区域淋巴结站,包括手术不常涉及部位,以区分局限与广泛受累。
- NST指征明确时,影像用于监测淋巴结对药物的在体反应,并最终帮助确定NST后手术方式。
- 活检结果不可用时,可依据各影像检查的相对有用性和缺点进行选择应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Metastatic lymph node involvement in breast cancer is a key determinant of the overall stage of disease and prognosis. Historically, lymph node status was determined by surgery first, with adjuvant treatments determined based on the results of the final surgical pathologic analysis. While this sequence is still applicable in many cases, neoadjuvant systemic treatment (NST) is increasingly being administered as the initial treatment. In cases that demonstrate good therapeutic response to drug therapies, NST may permit the option to perform less radical surgeries subsequently. Current breast cancer treatment has become multidisciplinary, with overlapping roles from the different disciplines. As surgery may be postponed, imaging and image-guided lymph node interventions have gained importance as the primary means of lymph node assessment. Imaging enables evaluation of all regional nodal basins, including locations where surgery is not usually performed. By differentiating limited versus extensive nodal involvement, imaging findings help determine whether initial treatment should be surgical or medical. If medical treatment with NST is indicated, imaging is performed to monitor the in vivo nodal response to drug therapy and ultimately to help determine the surgical technique to perform on the basis of the final imaging findings after NST. The authors discuss the imaging features of nodal metastases and the indications and techniques for the various image-guided procedures. The relative usefulness and shortcomings of the various imaging examinations are reviewed to discuss how they can be applied when biopsy results are not available. The role of imaging in the multidisciplinary team approach is emphasized based on past clinical trials of lymph node management and recent evolving knowledge of breast cancer staging. Online supplemental material is available for this article. ©RSNA, 2021.
引用
- Chung HL, Le-Petross HT, Leung JWT, et al. Imaging Updates to Breast Cancer Lymph Node Management. Radiographics. 2021. PMID: 34469221. doi:10.1148/rg.2021210053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。